Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study
Anna Mizielska(Poznan University of Medical Sciences), Błażej Rubiś(Poznan University of Medical Sciences), Izabela Kosmalska(Poznan University of Medical Sciences), Ewa Totoń(Poznan University of Medical Sciences), Klaudia Wilkowska(Poznan University of Medical Sciences), Natalia Lisiak(Poznan University of Medical Sciences), Marta Rymarczyk(Poznan University of Medical Sciences), Małgorzata Dąbrowska(Poznan University of Medical Sciences), Barbara Jacczak(Poznan University of Medical Sciences), Iga Dziechciowska(Poznan University of Medical Sciences), Radosław Szczepański(Poznan University of Medical Sciences), Małgorzata Cisek(Instytut Oceanologii Polskiej Akademii Nauk), Jan Ślężak(Poznan University of Medical Sciences)
Cited by 17
Related Papers
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
Interannual changes in zooplankton on the West Spitsbergen Shelf in relation to hydrography and their consequences for the diet of planktivorous seabirds
|ICES Journal of Marine Science|2012|82
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
|International Journal of Molecular Sciences|2019|42